Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage
- 135 Downloads
Cerebral vasospasm following subarachnoid haemorrhage (SAH) remains one of the major factors contributing to poor overall patient outcome. Prostaglandin F2-alpha (PGF2a) induces vasoconstriction. After SAH, PGF2a leads to cerebral inflammation and enhanced vasoconstriction, resulting in cerebral vasospasm. Losartan is already known to have beneficial effects in stroke models and also on several cerebral inflammatory processes. Therefore, the aim of the study was to analyse the effect of losartan on PGF2a-enhanced vasoconstriction after SAH.
To investigate the effect of losartan on PGF2a-enhanced vasoconstriction after SAH, cerebral vasospasm was induced by a double-haemorrhage model. Rats were killed on day 3 and 5 after SAH followed by measurement of the isometric force of basilar artery ring segments in an organ bath.
PGF2a induced a dose-dependent contraction. After pre-incubation with losartan, the maximum contraction (Emax) for sham-operated animals was significantly lowered [Emax 6% in losartan 3 × 10−4 molar (M) vs. 56% without losartan]. Also, after induced SAH, PGF2a induced no vasoconstriction in pre-incubated vessels with losartan 3 × 10−4 M on day 3 (d3) as well as on day 5 (d5). For the vasorelaxative investigations, vessel segments were pre-incubated with PFG2a. Cumulative application of losartan completely resolved the pre-contraction in sham-operated animals (non SAH: 95% relaxation). After SAH, losartan not only resolved the pre-contraction (d5: 103%), but also exceeded the pre-contraction (d3: 119%). Therefore, a statistically significantly increased and earlier relaxation was calculated for all losartan concentrations [Emax (d3/d5) and pD2 (d3/d5)] compared with the solvent control group.
In a physiological and pathophysiological setup, losartan reduces a PGF2-induced vasoconstriction and reverses a PGF2a-precontraction completely. This fact can be integrated in pushing forward further concepts trying to antagonise/prevent cerebral vasospasm after SAH.
KeywordsCerebrovasculature Losartan ET-1 Endothelin-1 SAH Aneurysmal subarachnoid haemorrhage Cerebral vasospasm Prostaglandin F2alpha PGF2a
We thank Marina Heibel for her excellent technical support. Furthermore, we are grateful for the experimental assistance of Dr. med. Vet. A. Theisen.
This study was not funded.
Compliance with ethical standards
Conflict of interest
The authors confirm that this article content has no conflicts of interest. The authors have no personal, financial or institutional interest in any of the drugs, materials or devices described in this article.
All applicable international, national and/or institutional guidelines for the care and use of animals were followed.
- 1.Konczalla J, Wanderer S, Mrosek J, Schuss P, Platz J, Güresir E, Seifert V, Vatter H (2013) Crosstalk between the Angiotensin and endothelin-system in the cerebrovasculature. Curr Neurovasc Res 10:335–345Google Scholar
- 2.Wanderer S, Mrosek J, Vatter H, Seifert V, Konczalla J (2017) Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage. Neurosurg Rev. https://doi.org/10.1007/s10143-017-0887-z
- 13.Konczalla J, Vatter H, Weidauer S, Raabe A, Seifert V (2006) Alteration of the cerebrovascular function of endothelin B receptor after subarachnoidal hemorrhage in the rat. Exp Biol Med (Maywood) 231:1064–1068Google Scholar
- 16.Vatter H, Weidauer S, Konczalla J, Dettmann E, Zimmermann M, Raabe A, Preibisch C, Zanella FE, Seifert V (2006) Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model. Neurosurgery 58:1190–1197CrossRefPubMedGoogle Scholar
- 18.Asaeda M, Sakamoto M, Kurosaki M, Tabuchi S, Kamitani H, Yokota M, Watanabe T (2005) A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm. Neurosci Lett 373:222–225CrossRefPubMedGoogle Scholar
- 20.Chen S, Ma Q, Krafft PR, Hu Q, Rolland W 2nd, Sherchan P, Zhang J, Tang J, Zhang JH (2013) P2X7r/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiol Dis 58C:298–307Google Scholar
- 23.Seifert V, Stolke D, Kaever V, Dietz H (1987) Arachidonic acid metabolism following aneurysm rupture. Evaluation of cerebrospinal fluid and serum concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 in patients with subarachnoid hemorrhage. Surg Neurol 27:243–252CrossRefPubMedGoogle Scholar
- 25.Biancardi VC, Stranahan AM, Krause EG, de Kloet AD, Stern JE (2016) Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus. Am J Physiol Heart Circ Physiol 310(3):H404–H414CrossRefPubMedGoogle Scholar
- 27.Maeso R, Rodrigo E, Munoz-Garcia R, Navarro-Cid J, Ruilope LM, Lahera V et al (1997) Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide. J Hypertens 15(12 Pt 2):1677–1684CrossRefPubMedGoogle Scholar
- 31.Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G et al (2004) The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 24(4):467–474CrossRefPubMedGoogle Scholar